⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LNAI News
Lunai Bioworks Inc. Common Stock
Lunai Bioworks logra la regresión completa de tumores pancreáticos primarios y metastásicos USA - español APAC - English USA - English APAC - Traditional Chinese USA - Français
prnewswire.com
LNAI
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy USA - English APAC - English
prnewswire.com
LNAI
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
prnewswire.com
LNAI
Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds
accessnewswire.com
LNAI
Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement
accessnewswire.com
LNAI
Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline
accessnewswire.com
LNAI
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense
accessnewswire.com
LNAI